Mature megakaryocytes are large, polyploid bone marrow cells that give rise to circulating platelets (1). Thrombopoietin (TPO) 1 has been characterized as the primary hematopoietic cytokine regulating normal megakaryocyte (MK) development. The receptor for TPO is encoded by the c-mpl proto-oncogene, a member of the hematopoietic growth factor receptor family, which in altered form causes a myeloproliferative syndrome in mice (2). In addition to its effects on MK development, TPO has been found to play a significant role in promoting stem cell survival, and in conjunction with other cytokines, it can support stem cell expansion (3-5). Characterization of the pathways by which TPO signals to promote survival and proliferation in stem cells and developing MKs is critical to a better understanding of the physiologic, pathologic, and potentially therapeutic roles of the cytokine in stem cell expansion, myeloproliferative disorders, and states of bone marrow failure.Many of the effects of TPO on cell survival and proliferation have been ascribed to activation of the Jak/STAT and Ras/Raf/ MAPK pathways (reviewed in Ref. 6). Activation of Jak2 leads to tyrosine phosphorylation of Mpl as well as STAT3 and STAT5 (7,8), and the phosphorylated STATs dimerize and translocate to the nucleus, where they stimulate transcription. In addition, phosphorylation of distal tyrosine residues on Mpl creates docking sites for SHC, which undergoes phosphorylation and then recruits Grb2/SOS, thus activating the Ras/Raf/ MAPK pathway (8 -10). Activation of the Ras/Raf/MAPK pathway can also occur by an alternative, as yet undetermined mechanism, independent of the distal receptor phosphotyrosine residues (11).Although these studies and others have shown that activation of the Jak/STAT and Ras/Raf/MAPK pathways is important for signaling by Mpl, other pathways likely contribute to the cellular response to TPO. One such pathway that may contribute to Mpl signaling is phosphatidylinositol 3-kinase (PI3K). PI3K has been shown to be activated by many growth factors involved in hematopoiesis, including stem cell factor, platelet-derived growth factor, erythropoietin, interleukin 3 (IL-3), IL-2, granulocyte-macrophage colony-stimulating factor, granulocyte colony stimulating factor, insulin-like growth factor 1, and TPO (12-16). It has been well established that activation of PI3K plays an important role in promoting cell survival (17-19). However, although there are ample data supporting a requirement for PI3K in proliferation of nonhematopoietic cells (20 -22), data showing specific requirements for PI3K in the cytokine-dependent proliferation of hematopoietic cells are inconclusive. Studies in cell lines with IL-2, IL-3, and erythropoietin have supported a role for PI3K in the proliferative response (23-26); however, studies with Flt-3L have not (27). Importantly, the conclusions from studies performed in primary cells often differ from those performed in cell lines. For example, data from cell lines support the role of PI3K in erythropoietin-...